Less is more: Effective deprescribing in community settings: A systematic review and meta-analysis
Abstract
Background: Potentially inappropriate medications (PIMs) and polypharmacy are common and associated with adverse health outcomes and increased healthcare costs. While deprescribing interventions have been widely studied in clinical and institutional settings, their effectiveness and economic impact in community settings remain insufficiently synthesized. This study aimed to evaluate the effectiveness of deprescribing interventions in reducing PIM use and improving economic outcomes.
Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines, searching Embase, CENTRAL, and MEDLINE up to April 2025. Studies evaluating deprescribing interventions in community-based settings were included, with the exclusion of non-original research, qualitative studies, and non-community settings. Data extraction followed a standardized protocol. Risk of bias was assessed using validated tools for randomized and non-randomized studies. Random-effects meta-analysis was performed for studies reporting comparable outcomes.
Results: Twenty-seven studies were included, of which nine contributed to the meta-analysis. Deprescribing interventions were associated with a statistically significant reduction in medication use, including PIMs (effect size −0.32, SE = 0.14, 95% CI: [-0.59; -0.05]), indicating a modest but consistent effect across studies. Reductions in inappropriate prescribing were observed across the majority of included studies in community-based settings. Eight studies reporting economic outcomes indicated consistent cost reductions or favorable cost-effectiveness profiles.
Conclusions: Deprescribing interventions in community-based settings are effective in reducing inappropriate medication use and may contribute to improved economic outcomes. These findings support the integration of deprescribing strategies into routine care. Further research is needed to assess long-term effects and implementation across diverse healthcare systems.
Key messages: • Deprescribing reduces potentially inappropriate medication use in community-based settings.
• Implementation of deprescribing may improve efficiency and reduce healthcare costs.
Related
- Effectiveness of green health prescribing and nature-based interventions in primary care and community settings for older adults: a systematic review of health, wellbeing and social outcomes
- Participatory action research in rural and vulnerable settings for community health: a systematic literature review.
- Shifting healthcare services from hospitals to community settings: implications for health inequalities – a systematic scoping review
- Community Pharmacists' Perspectives and Experiences of Deprescribing in Québec, Canada: Findings From a Survey
- Immune checkpoint inhibitors across neoadjuvant, perioperative, and adjuvant settings for resectable non-small-cell lung cancer: a systematic review and meta-analysis of randomized trials
BibTeX
@article{hama2026less,
title = {{Less is more: Effective deprescribing in community settings: A systematic review and meta-analysis}},
author = {H Hama and R Afzali and J Lanzerstorfer and L Lehner and J Kehr and I Grabovac},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.779},
url = {https://doi.org/10.1093/eurpub/ckag169.779},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Less is more: Effective deprescribing in community settings: A systematic review and meta-analysis
AU - H Hama
AU - R Afzali
AU - J Lanzerstorfer
AU - L Lehner
AU - J Kehr
AU - I Grabovac
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.779
UR - https://doi.org/10.1093/eurpub/ckag169.779
AB - Background: Potentially inappropriate medications (PIMs) and polypharmacy are common and associated with adverse health outcomes and increased healthcare costs. While deprescribing interventions have been widely studied in clinical and institutional settings, their effectiveness and economic impact in community settings remain insufficiently synthesized. This study aimed to evaluate the effectiveness of deprescribing interventions in reducing PIM use and improving economic outcomes. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines, searching Embase, CENTRAL, and MEDLINE up to April 2025. Studies evaluating deprescribing interventions in community-based settings were included, with the exclusion of non-original research, qualitative studies, and non-community settings. Data extraction followed a standardized protocol. Risk of bias was assessed using validated tools for randomized and non-randomized studies. Random-effects meta-analysis was performed for studies reporting comparable outcomes. Results: Twenty-seven studies were included, of which nine contributed to the meta-analysis. Deprescribing interventions were associated with a statistically significant reduction in medication use, including PIMs (effect size −0.32, SE = 0.14, 95% CI: [-0.59; -0.05]), indicating a modest but consistent effect across studies. Reductions in inappropriate prescribing were observed across the majority of included studies in community-based settings. Eight studies reporting economic outcomes indicated consistent cost reductions or favorable cost-effectiveness profiles. Conclusions: Deprescribing interventions in community-based settings are effective in reducing inappropriate medication use and may contribute to improved economic outcomes. These findings support the integration of deprescribing strategies into routine care. Further research is needed to assess long-term effects and implementation across diverse healthcare systems. Key messages: • Deprescribing reduces potentially inappropriate medication use in community-based settings. • Implementation of deprescribing may improve efficiency and reduce healthcare costs.
SN - 1101-1262
SN - 1464-360X
ER -